Dennis Helling - 03 Nov 2023 Form 4 Insider Report for Tabula Rasa HealthCare, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 03 Nov 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Nov 2023, 20:50:08 UTC
Prior SEC filing: 13 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Brian W. Adams

Key filing fact

Dennis Helling filed Form 4 for Tabula Rasa HealthCare, Inc. on 14 Nov 2023.

Key facts

This page summarizes Dennis Helling's Form 4 filing for Tabula Rasa HealthCare, Inc..
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Nov 2023, 20:50.

Change

Previous filing in this sequence was filed on 13 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TRHC transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -82,676
Change %: -74%
Price
Shares after: 29,433
Date: 03 Nov 2023
Ownership: Direct
Footnotes: F1

TRHC transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -3,792
Change %: -13%
Price
Shares after: 25,641
Date: 03 Nov 2023
Ownership: Direct
Footnotes: F2

TRHC transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -25,641
Change %: -100%
Price
Shares after: 0
Date: 03 Nov 2023
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TRHC transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value: $0
Shares: -2,369
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 03 Nov 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,369
Exercise price: $14.00
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Dennis Helling is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

Upon the consummation of the merger (the "Merger") contemplated by that certain Agreement and Plan of Merger, by and among Tabula Rasa HealthCare, Inc. (the "Company"), Locke Buyer, LLC and Locke Merger Sub, Inc., dated August 5, 2023 (the "Merger Agreement"), 82,676 shares of common stock of the Company ("Common Stock") were converted into the right to receive a cash payment of $868,098, representing the product obtained by multiplying (x) aggregate number of shares of Common Stock owned by the reporting person, by (y) the offer price ($10.50).

Footnote F2

Upon the consummation of the Merger, pursuant to the Merger Agreement, 3,792 outstanding restricted stock units ("RSUs") were cancelled and converted into the right to receive a cash payment of $39,816, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSUs, by (y) the offer price ($10.50).

Footnote F3

Upon the consummation of the Merger, pursuant to the Merger Agreement, 25,641 unvested restricted stock awards ("RSAs") were cancelled and converted into the right to receive a cash payment of $269,230.50, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSAs, by (y) the offer price ($10.50).

Footnote F4

Pursuant to the Merger Agreement, any stock option with an exercise price per share of Common Stock that was equal to or greater than the offer price ($10.50) was to be cancelled for no consideration. Accordingly, upon the consummation of the Merger, 2,369 stock options were cancelled for no consideration, as the exercise price per share of Common Stock was $14.